ALNY vs UTHR: stock comparison and AI forecast
Alnylam Pharmaceuticals, Inc. (ALNY) and United Therapeutics Corp (UTHR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALNY Alnylam Pharmaceuticals, Inc.
- Price
- $155.94 -47.3% · 6M
- Market Cap
- $20.89B
- P/E Ratio
- 7.3x
- Size
- large-cap
- AI Forecast
UTHR United Therapeutics Corp
- Price
- $562.02 -1.3% · 6M
- Market Cap
- $24.11B
- P/E Ratio
- 21.2x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- UTHR is 1.2 times larger than ALNY by market capitalization ($24.11B against $20.89B).
- ALNY trades at 7.3 times trailing earnings, UTHR at 21.2 times.
- Over the last six months UTHR returned -1.3% and ALNY -47.3%.
- ALNY turns 44.2% of its revenue into net income, against 38.6% for UTHR.
- ALNY carries 1.22 times debt per unit of equity, against 0.12 times for UTHR.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALNY | UTHR |
|---|---|---|
| Market Cap | $20.89B | $24.11B |
| P/E Ratio | 7.33x | 21.24x |
| P/B Ratio | 5.80x | 3.84x |
| EPS | $21.27 | $26.46 |
| Book Value/Share | $26.91 | $146.33 |
| Revenue/Share | – | $74.32 |
| FCF/Share | – | $20.22 |
Profitability & Margins
| Metric | ALNY | UTHR |
|---|---|---|
| ROE | 76.8% | 19.6% |
| ROA | 34.6% | 17.5% |
| ROIC | 22.7% | 20.6% |
| Gross Margin | 78.7% | 86.3% |
| Operating Margin | 21.5% | 41.5% |
| Net Margin | 44.2% | 38.6% |
| EBT Margin | 17.5% | 47.3% |
| Tax Rate | -174.3% | 18.4% |
Financial Health
| Metric | ALNY | UTHR |
|---|---|---|
| Current Ratio | 2.48x | 4.61x |
| Quick Ratio | 2.43x | 4.29x |
| D/E Ratio | 1.22x | 0.12x |
| Financial Leverage | 2.22x | 1.12x |
| Interest Coverage | 4.7x | 162.0x |
| Working Capital | $3.05B | $2.26B |
Cash Flow
| Metric | ALNY | UTHR |
|---|---|---|
| Operating Cash Flow | $1.23B | $1.43B |
| Free Cash Flow | – | $867M |
| Capital Spending | – | -$562M |
| OCF Growth YoY | – | -8.1% |
| FCF Growth YoY | – | -22.7% |
| FCF/Sales | – | 27.2% |
| CapEx/Sales | – | 17.6% |
Operational Efficiency
| Metric | ALNY | UTHR |
|---|---|---|
| Asset Turnover | – | 0.45x |
| Receivables Turnover | – | 9.1x |
| Inventory Turnover | 12.6x | 2.2x |
| Fixed Assets Turnover | – | 1.6x |
| Days Sales Outstanding | – | 40 days |
| Days Inventory | 29 days | 169 days |
| Payables Period | 37 days | 436 days |
| Cash Conversion Cycle | – | -227 days |
Income Statement
| Metric | ALNY | UTHR |
|---|---|---|
| Total Revenue | – | $3.19B |
| Operating Income | $1.35B | $1.32B |
| Net Income | $2.77B | $1.23B |
| R&D Expense | $1.92B | $703M |
| SG&A Expense | $1.66B | $728M |
| Cost of Goods Sold | $1.33B | $435M |
Dividend & Shareholder Information
| Metric | ALNY | UTHR |
|---|---|---|
| Shares Outstanding | 134M | 43M |
| Net Income Growth | – | -3.2% |
| EPS Growth | – | 0.1% |
ALNY vs UTHR: stock comparison and AI forecast
Which is bigger, ALNY or UTHR?
UTHR is 1.2 times larger than ALNY by market capitalization ($24.11B against $20.89B).
Which is cheaper on earnings, ALNY or UTHR?
ALNY trades at 7.3 times trailing earnings, UTHR at 21.2 times.
Which stock performed better over the last six months, ALNY or UTHR?
Over the last six months UTHR returned -1.3% and ALNY -47.3%.
Which one does Intratio's AI model rank higher, ALNY or UTHR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.